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Supplementary Materials -Leverrier et al., 2019 S -1 Some individual data were missing and consequently the number of subjects included in the statistical analysis changed for some parameters: a Blood glucose: 19,18,18 and 17 subjects analysed at week 3, 6, 9 and 12, respectively, for placebo against 26,27,27 and 28, respectively, for sunflower extract b HbA1c: 18, 17, 17 and 16 subjects analysed at week 3, 6, 9 and 12, respectively, for placebo against 25,27,27,27, respectively, for sunflower extract c For LDL, and consequently LDL/HDL ratio, the number of analysed subjects were 18 at week 3 and then 17 at weeks 6-12, for placebo, and 28 at week 3 and the 26 at weeks 6-12, for sunflower extract d FFA: 18 subjects analysed for all weeks for placebo, against 26, 27, 28 and 28 subjects at week 3, 6, 9 and 12 respectively for sunflower extract S -3 Some individual data were missing and consequently the number of subjects included in the statistical analysis changed for some parameters: a Blood glucose: 16 subjects were analysed at week 3 and 17 subjects for the 3 remaining visits, for placebo, against 26 subjects analysed for all the visit for sunflower extract b HbA1c: 15,16,16, and 15 subjects analysed at week 3, 6, 9 and 12, respectively, for placebo against 25, 26, 26 and 26 subjects, respectively, for sunflower extract c For LDL: 16 subjects were analysed at all weeks for placebo, against 26 subjects at week 3 and then 24 subjects at week 6-12 for sunflower extract. For HDL: 17 subjects were analysed at all weeks for placebo, against 27 subjects at week 3, 25 at weeks 6 and 9, and 26 at week 12 for sunflower extract. For LDL/HDL ratio: 16 subjects analysed for placebo for all the visits, against 26 at week 3 and then 24 at weeks 6-12 for sunflower extract d FFA: 16 subjects analysed at week 3 and then 17 for the remaining visits, for placebo, against 24, 25, 26 and 26 subjects at week 3, 6, 9 and 12, respectively, for sunflower extract Some individual data were missing and consequently the number of subjects included in the statistical analysis changed for some parameters: a HbA1c: 12 subjects were analysed at all the visits, for placebo, against 15 subjects for all the visit for sunflower extract b FFA: 12 subjects analysed at week 3 and then 13 subjects at the remaining visits, for placebo, against 13, 14, 15 and 15 subjects at week3, 6, 9 and 12, respectively for sunflower extract
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